SEARCH

SEARCH BY CITATION

References

  • Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. & Green, A.R. & Cancer Genome Project. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 10541061.
  • Brodsky, R.A. (2008) Paroxysmal nocturnal hemoglobinuria: stem cells and clonality. Hematology, American Society of Hematology Education Program, 2008, 111115.
  • Bruchova, H., Merkerova, M. & Prchal, J.T. (2008) Aberrant expression of microRNA in polycythemia vera. Haematologica, 93, 10091016.
  • Dameshek, W. (1969) Foreword and a proposal for considering paroxysmal nocturnal hemoglobinuria (PNH) as a “candidate” myeloproliferative disorder. Blood, 33, 263264.
  • Fouassier, M., Girodon, F., Cleyrat, C., Robillard, N., Garand, R. & Hermouet, S. (2009) Absence of JAK2-V617F in paroxysmal nocturnal haemoglobinuria-associated thrombosis. Thrombosis and Haemostasis, 102, 180182.
  • Inoue, N., Izui-Sarumaru, T., Murakami, Y., Endo, Y., Nishimura, J., Kuwayama, M., Shime, H., Machii, T., Kanakura, Y., Meyers, G., Wittwer, C., Chen, Z., Babcock, W., Frei-Lahr, D., Parker, C.J. & Kinoshita, T. (2006) Molecular basis of clonal expansion of hematopoiesis in two patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood, 108, 42324236.
  • Larsen, T.S., Christensen, J.H., Hasselbalch, H.C. & Pallisgaard, N. (2007) The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders. British Journal of Haematology, 136, 745751.
  • Odero, M.D., Grand, F.H., Iqbal, S., Ross, F., Roman, J.P., Vizmanos, J.L., Andrieux, J., Lai, J.L., Calasanz, M.J. & Cross, N.C. (2005) Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia, 19, 245252.
  • Passamonti, F., Rumi, E., Pietra, D., Lazzarino, M. & Cazzola, M. (2007) JAK2 (V617F) mutation in healthy individuals. British Journal of Haematology, 136, 678679.
  • Sugimori, C., Padron, E., Caceres, G., Shain, K., Sokol, L., Zhang, L., Tiu, R., O'Keefe, C.L., Afable, M., Clemente, M., Lee, J.M., Maciejewski, J.P., List, A.F., Epling-Burnette, P.K. & Araten, D.J. (2012) Paroxysmal nocturnal hemoglobinuria and concurrent JAK2 V617F mutation. Blood Cancer Journal, 2, e63.